After earning a B.S. in zoology from The University of Maryland and a doctorate in genetics from George Washington University, Dr. Clay Siegall founded Seattle Genetics (SG) in 1998 as a biotech firm specializing in therapy drugs that are designed to target cancer more tolerably and effectively than prior treatments. SG developed ADCetris, the first […]